The American Society of Plastic Surgeons (ASPS) has become the first major medical association to formally recommend against permanent “gender-affirming” surgeries for minors, marking a notable shift in professional guidance amid growing concerns over long-term outcomes and regret.

The ASPS position follows a $2 million medical malpractice award to Fox Varian, a 22-year-old detransitioner who sued New York doctors for performing a double mastectomy at age 16 when she identified as male. Varian later detransitioned, returning to living as her birth sex, and claimed the physicians pushed her into irreversible surgery without adequately considering alternatives or risks. Detransitioning involves stopping or reversing social, hormonal, or surgical transition steps after an individual concludes they no longer identify as transgender.

The ASPS recommendation aligns with increasing scrutiny of youth gender interventions, as evidence mounts of potential regret, complications, and insufficient long-term data on outcomes for minors.

Conservatives and medical skeptics have praised the move as a long-overdue recognition of caution and child protection, arguing that irreversible procedures should be reserved for adults capable of fully informed consent.

The Varian case, the first successful detransitioner malpractice lawsuit, has intensified calls for stricter standards, age restrictions, and accountability in the gender-medicine field.

The ASPS guidance is expected to influence other medical societies, insurance coverage decisions, and state-level policies on youth gender care, as debates over medical ethics, parental rights, and evidence-based practice continue to intensify nationwide.